Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
20833 | 383 | 42.2 | 60% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
989 | 10020 | CHRONIC MYELOID LEUKEMIA//IMATINIB//BCR ABL |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | V ERB B | Author keyword | 4 | 75% | 1% | 3 |
2 | V ERBB | Author keyword | 4 | 46% | 2% | 6 |
3 | ACUTE RETROVIRUS | Author keyword | 1 | 50% | 0% | 1 |
4 | EGF ERBB RECEPTORS | Author keyword | 1 | 50% | 0% | 1 |
5 | EGFR ERBB | Author keyword | 1 | 50% | 0% | 1 |
6 | ERYTHROID PROGENITOR SELF RENEWAL | Author keyword | 1 | 50% | 0% | 1 |
7 | MYCER | Author keyword | 1 | 50% | 0% | 1 |
8 | STE 20 | Author keyword | 1 | 50% | 0% | 1 |
9 | VIRUS INDUCED CARCINOGENESIS | Author keyword | 1 | 50% | 0% | 1 |
10 | DOMINANT NEGATIVE RAS | Author keyword | 0 | 33% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | V ERB B | 4 | 75% | 1% | 3 | Search V+ERB+B | Search V+ERB+B |
2 | V ERBB | 4 | 46% | 2% | 6 | Search V+ERBB | Search V+ERBB |
3 | ACUTE RETROVIRUS | 1 | 50% | 0% | 1 | Search ACUTE+RETROVIRUS | Search ACUTE+RETROVIRUS |
4 | EGF ERBB RECEPTORS | 1 | 50% | 0% | 1 | Search EGF+ERBB+RECEPTORS | Search EGF+ERBB+RECEPTORS |
5 | EGFR ERBB | 1 | 50% | 0% | 1 | Search EGFR+ERBB | Search EGFR+ERBB |
6 | ERYTHROID PROGENITOR SELF RENEWAL | 1 | 50% | 0% | 1 | Search ERYTHROID+PROGENITOR+SELF+RENEWAL | Search ERYTHROID+PROGENITOR+SELF+RENEWAL |
7 | MYCER | 1 | 50% | 0% | 1 | Search MYCER | Search MYCER |
8 | STE 20 | 1 | 50% | 0% | 1 | Search STE+20 | Search STE+20 |
9 | VIRUS INDUCED CARCINOGENESIS | 1 | 50% | 0% | 1 | Search VIRUS+INDUCED+CARCINOGENESIS | Search VIRUS+INDUCED+CARCINOGENESIS |
10 | DOMINANT NEGATIVE RAS | 0 | 33% | 0% | 1 | Search DOMINANT+NEGATIVE+RAS | Search DOMINANT+NEGATIVE+RAS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TISSUE SPECIFIC TRANSFORMATION | 13 | 71% | 3% | 10 |
2 | AVIAN ERYTHROBLASTOSIS VIRUS | 11 | 26% | 10% | 37 |
3 | V ERBB | 8 | 62% | 2% | 8 |
4 | C ERBB | 8 | 36% | 4% | 17 |
5 | B ONCOGENE PROTEIN | 6 | 100% | 1% | 4 |
6 | RETROVIRUS MH2 | 3 | 100% | 1% | 3 |
7 | V MIL | 3 | 50% | 1% | 4 |
8 | MAMMALIAN CELL TRANSFORMATION | 2 | 67% | 1% | 2 |
9 | ERYTHROBLASTOSIS VIRUS | 2 | 36% | 1% | 4 |
10 | MYELOCYTOMATOSIS VIRUS | 2 | 43% | 1% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
CELL-TRANSFORMATION BY THE EPIDERMAL GROWTH-FACTOR RECEPTOR AND V-ERBB | 1991 | 32 | 39 | 41% |
ROLE OF THE V-ERBA AND V-ERBB ONCOGENES OF AVIAN ERYTHROBLASTOSIS VIRUS IN ERYTHROID CELL-TRANSFORMATION | 1983 | 170 | 3 | 100% |
AVIAN HEMATOPOIETIC-CELL CULTURE - IN-VITRO MODEL SYSTEMS TO STUDY ONCOGENIC TRANSFORMATION OF HEMATOPOIETIC-CELLS | 1995 | 7 | 40 | 35% |
ON THE HETEROGENEITY OF SERUM-ALBUMIN | 1987 | 17 | 9 | 78% |
The epidermal growth factor receptor gene family as a target for therapeutic intervention in numerous cancers: what's genetics got to do with it? | 2005 | 36 | 134 | 15% |
LEUKEMIA AS A MULTISTEP PROCESS - STUDIES WITH AVIAN RETROVIRUSES CONTAINING 2 ONCOGENES | 1988 | 15 | 29 | 48% |
Acute avian leukemia viruses as tools to study hematopoietic cell differentiation | 1996 | 8 | 89 | 27% |
CO-OPERATION BETWEEN VIRAL ONCOGENES IN AVIAN ERYTHROID AND MYELOID-LEUKEMIA | 1989 | 15 | 31 | 35% |
INTERACTION OF RETROVIRAL ONCOGENES WITH THE DIFFERENTIATION PROGRAM OF MYOGENIC CELLS | 1987 | 49 | 76 | 25% |
ERB-B - GROWTH-FACTOR RECEPTOR TURNED ONCOGENE | 1986 | 15 | 23 | 57% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NAT SCI MOLEC BIOL | 0 | 25% | 0.3% | 1 |
2 | EM P PER CLIN IMMUNOL | 0 | 13% | 0.3% | 1 |
3 | MED CANC BIOCHEM | 0 | 11% | 0.3% | 1 |
4 | 3 ONCOL MOL | 0 | 100% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000236626 | MSSP//C MYC PROTEIN//ONCOGENE RESEARCH |
2 | 0.0000211162 | C FGR//TYROSINE PROTEIN KINASE//CSK |
3 | 0.0000163876 | C MYB//B MYB//V MYB |
4 | 0.0000155452 | AVIAN LEUKOSIS VIRUS//AVIAN LEUKOSIS VIRUS SUBGROUP J//MYELOID LEUKOSIS |
5 | 0.0000142095 | IMMUNOGENE//MED MOLEC BIOL SHINJUKU KU//ERBB PROTEINS |
6 | 0.0000133599 | RESISTANCE TO THYROID HORMONE//THYROID HORMONE RECEPTOR//V ERBA |
7 | 0.0000092124 | ETS 1//ETS DOMAIN//ETS FAMILY |
8 | 0.0000087830 | RAF//RAF 1//LEO JENKINS CANC |
9 | 0.0000086716 | ONCOGENIC RAS P21//EFFECTOR DOMAINS//N RAS |
10 | 0.0000048355 | GM CSF RECEPTOR//BLAST COLONIES//COMMON BETA SUBUNIT |